Eribilin Injection
220.99$
172.37$
Eribilin injection, available in a 1 mg dosage, is an innovative anticancer treatment specifically designed for individuals battling metastatic breast cancer who have undergone at least two prior chemotherapy regimens. This medication is also indicated for patients with unresectable liposarcoma who have previously been treated with anthracycline-based therapies for advanced or metastatic conditions. Eribilin works by inhibiting the proliferation and spread of cancer cells, thereby helping to manage the progression of these challenging cancers. It is essential to monitor for potential side effects, as Eribilin may cause serious complications, including neutropenia, which can increase the risk of infections. Patients should discuss their medical history and any ongoing treatments with their healthcare provider to ensure safe use. As a powerful option for those with limited alternatives, Eribilin injection represents hope in the fight against aggressive cancer types. Always consult with a healthcare professional for personalized advice and to understand the full range of potential benefits and risks associated with this medication.
الكمية
Active Pharmaceutical Ingredient
Uses
• Eribilin injection is primarily indicated for the treatment of metastatic breast cancer, which occurs when cancer spreads beyond the original site. This condition can lead to various symptoms that significantly impact a patient's quality of life. By targeting cancer cells, Eribilin injection helps to manage the progression of the disease. Patients may experience relief from symptoms such as pain and discomfort in affected areas.
• The administration of Eribilin injection can also assist in alleviating symptoms associated with metastatic breast cancer, such as swelling in the affected regions. Reducing swelling can contribute to improved mobility and comfort for patients. As part of a comprehensive treatment plan, Eribilin injection plays a crucial role in addressing these distressing symptoms. This can enhance the overall well-being of individuals undergoing treatment.
• In addition to its role in managing physical symptoms, Eribilin injection may help improve the overall treatment outcomes for patients with metastatic breast cancer. By effectively targeting cancer cells, it supports the overall therapeutic strategy. This can lead to a reduction in the severity of symptoms like shortness of breath or persistent cough. Patients receiving Eribilin injection often report a better ability to engage in daily activities.
• Eribilin injection is also utilized when patients have not responded adequately to other treatments for metastatic breast cancer. It provides an alternative option for those seeking to manage their condition more effectively. The unique mechanism of action of Eribilin injection makes it a valuable tool in the oncologist's arsenal. By offering hope for improved symptom management, it plays a significant role in the care of patients facing this challenging diagnosis.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Eribilin Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer, such as breast lumps, bloody discharge from nipples, or changes in the shape or texture of the breast. Eribilin 1 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you. Soft tissue sarcoma (liposarcoma): Soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used for those who have received prior anthracycline-containing therapy and have not shown significant improvement. Side effects of Eribilin 1 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Eribilin Injection may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Eribilin 1 mg is given intravenously (in a vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor, or nurse in a hospital. The dosage and frequency of How Eribilin 1 mg Injection works depend on various factors, including your weight and height, your health problems, and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment, closely monitor the patient's blood cell count and peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Benefits of Eribilin 1 mg Injection. It may increase the risk of liver damage. It is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Eribilin 1 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Eribilin 1 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Uses of Eribilin 1 mg Injection. Eribilin Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Eribilin 1 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Benefits of Eribilin 1 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Eribilin 1 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Uses of Eribilin 1 mg Injection may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Side effects of Eribilin 1 mg Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Eribilin 1 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Eribilin 1 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Eribilin Injection.